These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16919150)

  • 1. ADHD abroad.
    Baverstock AC; Finlay F
    Child Care Health Dev; 2006 Sep; 32(5):611. PubMed ID: 16919150
    [No Abstract]   [Full Text] [Related]  

  • 2. ADHD drugs and cardiovascular risk.
    Nissen SE
    N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controls on ADHD drug should be reduced.
    Anderson PD
    Am Pharm; 1994 Sep; NS34(9):5. PubMed ID: 7977028
    [No Abstract]   [Full Text] [Related]  

  • 5. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 7. Who is using the drugs I prescribe?
    Winkelaar PG
    Can Fam Physician; 2002 May; 48():883. PubMed ID: 12053632
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of attention deficit hyperactivity disorder.
    Brown G
    Nurs Times; 2003 Jun 24-30; 99(25):34-6. PubMed ID: 12861637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate problems.
    N Engl J Med; 1971 Oct; 285(17):970. PubMed ID: 5096232
    [No Abstract]   [Full Text] [Related]  

  • 10. To box OR NOT TO box.
    Newstadt M
    J Ky Med Assoc; 2006 Aug; 104(8):344-5. PubMed ID: 16939037
    [No Abstract]   [Full Text] [Related]  

  • 11. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.
    Newcorn JH; Stein MA; Childress AC; Youcha S; White C; Enright G; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2013 Sep; 52(9):921-30. PubMed ID: 23972694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.
    Cottrell S; Tilden D; Robinson P; Bae J; Arellano J; Edgell E; Aristides M; Boye KS
    Value Health; 2008; 11(3):376-88. PubMed ID: 18489664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 15. Doctor shopping for medications used in the treatment of attention deficit hyperactivity disorder: shoppers often pay in cash and cross state lines.
    Cepeda MS; Fife D; Berwaerts J; Friedman A; Yuan Y; Mastrogiovanni G
    Am J Drug Alcohol Abuse; 2015 May; 41(3):226-9. PubMed ID: 25860878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(44):1439-43. PubMed ID: 21063274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Ritalin ad blitz makes parents jumpy.
    Novak V
    Time; 2001 Sep; 158(10):62-3. PubMed ID: 11558351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.